Increasing demand for outsourced services in pharmaceutical and biotechnology companies due to cost savings and efficiency gains.
Rising need for specialized expertise and advanced technologies in drug development and clinical trials.
Growing trend towards strategic partnerships and collaborations to streamline operations and drive innovation.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Services |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Atos SE, Boehringer Ingelheim International, Catalent, Inc, Labcorp Drug Development, Genpact, ICON plc, Infosys Limited, IBM, Lonza, Parexel, IQVIA Inc |
Regulatory challenges and compliance issues in different regions impacting the outsourcing process.
Concerns regarding data security and confidentiality leading to hesitancy in outsourcing sensitive tasks.